Eur J Nucl Med Mol Imaging (2014) 41:792–805 DOI 10.1007/s00259-013-2665-7
REVIEW ARTICLE
Highlights of the 26th EANM 2013 congress in Lyon: new horizons and further Frank Bengel & Rachele Bonfiglioli & Stefano Fanti
Received: 29 November 2013 / Accepted: 3 December 2013 / Published online: 28 January 2014 # Springer-Verlag Berlin Heidelberg 2014
Abstract The 26th European Association of Nuclear Medicine (EANM) annual congress was held in Lyon, France, under the chairmanship of Professor Dominique LeGuludec. The congress was attended by more than 5,200 participants, with about one-quarter coming from outside Europe. This review summarizes the major scientific contributions which were selected from the more than 1,700 submitted abstracts, and presented in the closing highlights session. They covered the diverse areas of nuclear medicine, with particular focus on oncology, cardiovascular science and neurology. Various innovations were reported regarding imaging methodology, physics, radiopharmaceuticals and chemistry. Novel radionuclide applications in both diagnosis and therapy were investigated and described, triggering strong interest from the many professionals involved. Significant progress has been demonstrated in the clinical use of existing nuclear medicine procedures, and a number of new applications are under development in preclinical and early clinical stages. The congress was a unique opportunity to get a thorough update on this research. Keywords Nuclear medicine . Annual congress 2013 . Lyon . Highlights . EANM
F. Bengel Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany R. Bonfiglioli : S. Fanti (*) Medicina Nucleare, Policlinico S.Orsola, Azienda Ospedaliera Universitaria di Bologna, Bologna, Italy e-mail: [email protected]
Introduction The EANM congress, held in Lyon, France, was again confirmed as one of the largest imaging meetings in the world, with more than 5,200 participants from 88 countries. Regarding attendance at this meeting, a most intriguing point is the constantly increasing popularity among non-European participants: at the 2012 congress in Milan for the first time there were more than 1,000 non-EU attendees, and the 2013 congress in Lyon set a new record with more than 1,200. The overall programme included 4 plenary sessions, 13 symposia, 58 scientific sessions, 13 featured sessions, 15 poster walks, 147 posters, 13 CME sessions and 4 presymposia. Original scientific work submitted comprised 1,753 abstracts, of which 1,500 were accepted. The majority came from Europe (about 75 %) but a relevant 15 % came from Asia and 5 % from America. Top submitting countries were Italy and France (about 170 abstracts each), followed by Spain and Turkey with about 100 each (Fig. 1). However, it is interesting to note an increase in submissions from nonEuropean countries, with 100 abstracts from Japan, 70 from India, 50 from the US and 40 from Korea. Categories of abstracts covered all relevant topics in nuclear medicine, with oncology remaining the single most relevant area (25 % for clinical papers), followed by conventional (12 %), molecular and multimodality (11 %), physics (10 %), cardiovascular (10 %), radiopharmaceuticals (10 %), therapy (9 %) and neuroscience (8 %). Given the excellent quality of the submitted abstracts, selection of work for the closing highlights lectures was challenging. Although guided by reviewer scores, it should be noted that ultimate inclusion was based on subjective
Eur J Nucl Med Mol Imaging (2014) 41:792–805 Fig. 1 Distribution of abstracts by country
793 Highlights Statistics
decisions of the lecturers seeking to represent important trends in the field. All authors who were invited to present, and especially those who provided slides of their work for possible inclusion in the highlights, should be congratulated for their contribution.
Cardiovascular science Although less extensively represented when compared to oncology, the area of cardiovascular nuclear imaging showcased novel trends which may benefit the entire field of radionuclide imaging. These included advanced technology to increase detection sensitivity for better images and reduced radiation dose, integrated multimodality imaging, and clinically relevant nonperfusion molecular imaging approaches. Zoccarato et al., in four different nuclear medicine centres, analysed new iterative reconstruction algorithms with resolution recovery (IR-RR) to halve the patient dose in SPECT myocardial perfusion imaging (MPI) [1]. The IR-RR algorithms provide significantly better results than conventional reconstruction with FBP and OSEM, with up to 50 % of standard counting statistics when left ventricular (LV) wall thickness was considered (p
REVIEW ARTICLE
Highlights of the 26th EANM 2013 congress in Lyon: new horizons and further Frank Bengel & Rachele Bonfiglioli & Stefano Fanti
Received: 29 November 2013 / Accepted: 3 December 2013 / Published online: 28 January 2014 # Springer-Verlag Berlin Heidelberg 2014
Abstract The 26th European Association of Nuclear Medicine (EANM) annual congress was held in Lyon, France, under the chairmanship of Professor Dominique LeGuludec. The congress was attended by more than 5,200 participants, with about one-quarter coming from outside Europe. This review summarizes the major scientific contributions which were selected from the more than 1,700 submitted abstracts, and presented in the closing highlights session. They covered the diverse areas of nuclear medicine, with particular focus on oncology, cardiovascular science and neurology. Various innovations were reported regarding imaging methodology, physics, radiopharmaceuticals and chemistry. Novel radionuclide applications in both diagnosis and therapy were investigated and described, triggering strong interest from the many professionals involved. Significant progress has been demonstrated in the clinical use of existing nuclear medicine procedures, and a number of new applications are under development in preclinical and early clinical stages. The congress was a unique opportunity to get a thorough update on this research. Keywords Nuclear medicine . Annual congress 2013 . Lyon . Highlights . EANM
F. Bengel Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany R. Bonfiglioli : S. Fanti (*) Medicina Nucleare, Policlinico S.Orsola, Azienda Ospedaliera Universitaria di Bologna, Bologna, Italy e-mail: [email protected]
Introduction The EANM congress, held in Lyon, France, was again confirmed as one of the largest imaging meetings in the world, with more than 5,200 participants from 88 countries. Regarding attendance at this meeting, a most intriguing point is the constantly increasing popularity among non-European participants: at the 2012 congress in Milan for the first time there were more than 1,000 non-EU attendees, and the 2013 congress in Lyon set a new record with more than 1,200. The overall programme included 4 plenary sessions, 13 symposia, 58 scientific sessions, 13 featured sessions, 15 poster walks, 147 posters, 13 CME sessions and 4 presymposia. Original scientific work submitted comprised 1,753 abstracts, of which 1,500 were accepted. The majority came from Europe (about 75 %) but a relevant 15 % came from Asia and 5 % from America. Top submitting countries were Italy and France (about 170 abstracts each), followed by Spain and Turkey with about 100 each (Fig. 1). However, it is interesting to note an increase in submissions from nonEuropean countries, with 100 abstracts from Japan, 70 from India, 50 from the US and 40 from Korea. Categories of abstracts covered all relevant topics in nuclear medicine, with oncology remaining the single most relevant area (25 % for clinical papers), followed by conventional (12 %), molecular and multimodality (11 %), physics (10 %), cardiovascular (10 %), radiopharmaceuticals (10 %), therapy (9 %) and neuroscience (8 %). Given the excellent quality of the submitted abstracts, selection of work for the closing highlights lectures was challenging. Although guided by reviewer scores, it should be noted that ultimate inclusion was based on subjective
Eur J Nucl Med Mol Imaging (2014) 41:792–805 Fig. 1 Distribution of abstracts by country
793 Highlights Statistics
decisions of the lecturers seeking to represent important trends in the field. All authors who were invited to present, and especially those who provided slides of their work for possible inclusion in the highlights, should be congratulated for their contribution.
Cardiovascular science Although less extensively represented when compared to oncology, the area of cardiovascular nuclear imaging showcased novel trends which may benefit the entire field of radionuclide imaging. These included advanced technology to increase detection sensitivity for better images and reduced radiation dose, integrated multimodality imaging, and clinically relevant nonperfusion molecular imaging approaches. Zoccarato et al., in four different nuclear medicine centres, analysed new iterative reconstruction algorithms with resolution recovery (IR-RR) to halve the patient dose in SPECT myocardial perfusion imaging (MPI) [1]. The IR-RR algorithms provide significantly better results than conventional reconstruction with FBP and OSEM, with up to 50 % of standard counting statistics when left ventricular (LV) wall thickness was considered (p
